Selective serotonin reuptake inhibitors and violent crime: do SSRI’s kill or cure?

Selective serotonin reuptake inhibitors and violent crime: do SSRI’s kill or cure?

Introduction SSRI’s are consistently associated with violent events in the adult population. However, the causality between SSRI use and violent behaviour was never found. Several recent studies draw the attention to this hypothesis while they were inspired by several mass murderers in the United S...

Descrizione completa

Dettagli Bibliografici
Autori principali:	S. Sneep, S. Petrykiv
Natura:	Articolo
Lingua:	English
Pubblicazione:	Cambridge University Press 2022-06-01
Serie:	European Psychiatry
Soggetti:	SSRI violent behaviour
Accesso online:	https://www.cambridge.org/core/product/identifier/S0924933822008926/type/journal_article

Documenti analoghi

Selective serotonin reuptake inhibitor (SSRI) antidepressant treatment discontinuation syndrome: A review of the clinical evidence and the possible mechanisms involved
di: Thibault eRenoir
Pubblicazione: (2013-04-01)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
di: Chad Compagner, et al.
Pubblicazione: (2021-01-01)

A comparative study of personality aspects of females with depression using the antidepressant medications: selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs)
di: Saeed Pournaghash tehrani, et al.
Pubblicazione: (2018-03-01)

Selective serotonin reuptake inhibitors related bleeding risk: case report and review of literature
di: Andrea Boccatonda, et al.
Pubblicazione: (2023-08-01)

Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake
di: Thomas Blom, et al.
Pubblicazione: (2020-07-01)

Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives
di: Atmaca M
Pubblicazione: (2020-04-01)

Serotonin Syndrome Due to Overdose Intake of SSRI
di: Yavuz Orak, et al.
Pubblicazione: (2015-08-01)

Supra-Therapeutic Selective Serotonin Reuptake Inhibitor (Ssri) Dosesfor Refractory Obsessive-Compulsive Disorder: A Case Report
di: Syed Faraz Zafar, et al.
Pubblicazione: (2024-04-01)

Post-Selective Serotonin Reuptake Inhibitor Sexual Dysfunctions (PSSD): Clinical Experience with a Multimodal Approach
di: Yacov Reisman, et al.
Pubblicazione: (2022-08-01)

The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on the offspring
di: Jocelien DA Olivier, et al.
Pubblicazione: (2013-05-01)

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases
di: Stefania Chiappini, et al.
Pubblicazione: (2022-05-01)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
di: Bernadette Mdawar, et al.
Pubblicazione: (2020-01-01)

Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI)
di: Malm Heli, et al.
Pubblicazione: (2012-12-01)

Prenatal selective serotonin reuptake inhibitor (SSRI) exposure induces working memory and social recognition deficits by disrupting inhibitory synaptic networks in male mice
di: Weonjin Yu, et al.
Pubblicazione: (2019-04-01)

A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer’s disease
di: Jinli Zhang, et al.
Pubblicazione: (2023-05-01)

The Role of Selective Serotonin Reuptake Inhibitors in Premature Ejaculation
di: Alka Aggarwal, et al.
Pubblicazione: (2017-08-01)

Prenatal Selective Serotonin Reuptake Inhibitor Exposure, Depression, and Brain Morphology in Middle Childhood: Results From the ABCD Study
di: Allison L. Moreau, et al.
Pubblicazione: (2023-04-01)

Characteristics of patients with anxiety disorder without selective serotonin reuptake inhibitor prescription over a two‐year period of pharmacotherapy
di: Keisuke Mori, et al.
Pubblicazione: (2024-03-01)

Cellular correlates of enhanced anxiety caused by acute treatment with the selective serotonin reuptake inhibitor fluoxetine in rats
di: Shilpa eRavinder, et al.
Pubblicazione: (2011-12-01)

Selective Serotonin Reuptake Inhibitors: Antimicrobial Activity Against ESKAPEE Bacteria and Mechanisms of Action
di: Thiago Hideo Endo, et al.
Pubblicazione: (2025-01-01)

Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
di: Najmeh Shahini, et al.
Pubblicazione: (2021-07-01)

Selective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort Study
di: Molero, Y, et al.
Pubblicazione: (2015)

SSRI use in pregnancy: Evaluating the risks and benefits
di: Elsa du Toit, et al.
Pubblicazione: (2015-05-01)

A Randomized, Double-blind, Placebo - controlled Study of Safety of the Adjunctive Saffron on Sexual Dysfunction Induced by a Selective Serotonin Reuptake Inhibitor
di: P Mansoori, et al.
Pubblicazione: (2011-03-01)

Comparison of the groups treated with mirtazapine and selective serotonine reuptake inhibitors with respect to birth outcomes and severity of psychiatric disorder
di: Buket Belkız Güngör, et al.
Pubblicazione: (2019-10-01)

THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) AS TREATMENT OF DEPRESSION IN PATIENTS WITH EPILEPSY
di: Yu. V. Solomatin, et al.
Pubblicazione: (2016-12-01)

Selective serotonin reuptake inhibitor (SSRI) antidepressants, prolactin and breast cancer
di: Janet eAshbury, et al.
Pubblicazione: (2012-12-01)

SSRI induced hypnic jerks: A case series
di: Rakesh Kumar, et al.
Pubblicazione: (2023-07-01)

Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned with Selective Serotonin Reuptake Inhibitor Drugs
di: Nastaran Eizadi-Mood, et al.
Pubblicazione: (2022-12-01)

WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.
di: Geddes, J, et al.
Pubblicazione: (2006)

Sexual dysfunction in patients with MDD treated with SSRIs - causes, measurement and prevention
di: Adrian Giermasinski, et al.
Pubblicazione: (2021-09-01)

Using functional neuroimaging to investigate the mechanisms of action of selective serotonin reuptake inhibitors (SSRIs).
di: Murphy, SE
Pubblicazione: (2010)

Pharmacogenetics of SSRIs and Sexual Dysfunction
di: Liana Osis, et al.
Pubblicazione: (2010-12-01)

The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID‐19 patients: A systematic review and meta‐analysis
di: Dena Firouzabadi, et al.
Pubblicazione: (2022-11-01)

Maternal use of selective serotonin reuptake inhibitors during pregnancy is associated with Hirschsprung’s disease in newborns – a nationwide cohort study
di: Sebastian Werngreen Nielsen, et al.
Pubblicazione: (2017-06-01)

Spontaneous Intracerebral Hemorrhage Due to Delta Storage Pool Disease in a Patient on a Serotonin-Norepinephrine Reuptake Inhibitor
di: Annette Leibetseder, et al.
Pubblicazione: (2019-11-01)

Cutting the First Turf to Heal Post-SSRI Sexual Dysfunction: A Male Retrospective Cohort Study
di: Rosaria De Luca, et al.
Pubblicazione: (2022-09-01)

Post-SSRI sexual dysfunction and SSRI induced sexual dysfunction - literature review
di: Eliasz Panek, et al.
Pubblicazione: (2023-04-01)

Efficacy of Selective Serotonin Reuptake Inhibitors (SSRIS) compared to placebo in obsessive compulsive disorder in adults
di: Soomro, G, et al.
Pubblicazione: (2008)

WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
di: Barbui, C, et al.
Pubblicazione: (2006)